M.D.C. Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" M.D.C. stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View analyst ratings for M.D.C. or view top-rated stocks.

4 brokers have issued 12 month target prices for M.D.C.'s shares. Their MDC stock forecasts range from $27.00 to $77.00. On average, they predict M.D.C.'s stock price to reach $47.67 in the next year. This suggests a possible upside of 51.6% from the stock's current price.
View analysts' price targets for M.D.C. or view top-rated stocks among Wall Street analysts.

M.D.C.'s stock was trading at $55.83 at the beginning of 2022. Since then, MDC shares have decreased by 43.7% and is now trading at $31.45.
View the best growth stocks for 2022 here.

M.D.C. is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for M.D.C..

M.D.C. Holdings, Inc. (NYSE:MDC) announced its earnings results on Thursday, April, 28th. The construction company reported $2.02 EPS for the quarter, beating the consensus estimate of $1.90 by $0.12. The construction company had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.22 billion. M.D.C. had a trailing twelve-month return on equity of 24.22% and a net margin of 11.24%. The company's quarterly revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.51 EPS.
View M.D.C.'s earnings history.

M.D.C. announced a quarterly dividend on Wednesday, April 27th. Stockholders of record on Wednesday, May 11th will be paid a dividend of $0.50 per share on Wednesday, May 25th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 6.36%. The ex-dividend date of this dividend is Tuesday, May 10th.
View M.D.C.'s dividend history.

M.D.C.(NYSE:MDC) pays an annual dividend of $2.00 per share and currently has a dividend yield of 6.36%. MDC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. M.D.C. has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of M.D.C. is 24.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 18.55% next year. This indicates that M.D.C. will be able to sustain or increase its dividend.
View M.D.C.'s dividend history.

Some companies that are related to M.D.C. include D.R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), Meritage Homes (MTH), KB Home (KBH), Tri Pointe Homes (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH) and Hovnanian Enterprises (HOV).
View all of MDC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C.'s stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.54%), Vanguard Group Inc. (9.01%), Dimensional Fund Advisors LP (5.96%), State Street Corp (3.54%), Hamlin Capital Management LLC (2.84%) and Principal Financial Group Inc. (1.86%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., LSV Asset Management, Jane Street Group LLC, Bahl & Gaynor Inc., Healthcare of Ontario Pension Plan Trust Fund, Mondrian Investment Partners LTD, SG Americas Securities LLC, and Bank of America Corp DE. Company insiders that have sold M.D.C. company stock in the last two years include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Robert Nathaniel Martin, and Staci M Woolsey.
View insider buying and selling activity for M.D.C. or view top insider-selling stocks.

MDC stock was acquired by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Hamlin Capital Management LLC, Invesco Ltd., First Trust Advisors LP, JPMorgan Chase & Co., Vanguard Group Inc., Cibc World Market Inc., and Edgestream Partners L.P..
View insider buying and selling activity for M.D.C. or or view top insider-buying stocks.

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDC stock can currently be purchased for approximately $31.45.

M.D.C. (NYSE:MDC) has a market capitalization of $2.24 billion and generates $5.25 billion in revenue each year. The construction company earns $573.66 million in net income (profit) each year or $8.329990 on an earnings per share basis.

M.D.C. employs 2,080 workers across the globe.

M.D.C. was founded in 1972.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The official website for M.D.C. is www.mdcholdings.com. The construction company can be reached via phone at (303) 773-1100, via email at [email protected], or via fax at 303-771-3461.